Blogs about: Association Of The British Pharmaceutical Industry

Featured Blog

Truth of an industry and the transparency of a profession

Snow-Leavis wrote 2 months ago: GlaxoSmithKline is fined record $3bn in US, published 3 July 2012, as:BMJ2012;345:e4568 http://www.b … more →

Tags: Medical writings, Medical Education, Pharmaceutical industry and Medical Education, British Medical Journal, NHS Hospitality Registers, BMJ, Medical Education, Stephen Whitehead, GlaxoSmithKline

Drugs companies 'are putting profits ahead of medical discoveries', claims hard-hitting report

Ralph Turchiano wrote 9 months ago: For every £1 spent on basic research a  whopping £19 is spent on marketing, claim experts Current re … more →

Tags: All posts, Pharmaceutical - Medical Devices, societal, Corruption - Ghost Writing - Fabricated Data, Control, Inhibiting Self Determination, condescending, BMJ, HIV, Pharmaceutical Industry, London School of Economics

Handy hints for getting along with your drug company1 comment

Carolyn Thomas wrote 1 year ago: Pity the poor pharmaceutical industry, much maligned by those concerned about marketing-based medici … more →

Tags: Lying for fun and profit, Big Pharma, selling sickness, ray moynihan, key opinion leader, sunshine act, Ethical Standards in Health & Life Sciences Group

Spirit of ad-venture shown by charities in funding drug research or a sign of desperate times?

simondenegri wrote 1 year ago: From The Economist in New York, a short but interesting piece on the growing collaboration between c … more →

Tags: Medical Research, Cancer Research UK, Pharmaceutical Industry, Wellcome Trust, united states, charitable organization, London, New York, Drug Development

Pradaxa Website Violates British Code Of Conduct

Sadaka Associates wrote 1 year ago: Pradaxa continues to be a newsmaker in the pharmaceutical industry.  As, the makers of Pradaxa have … more →

Tags: Drug Safety News, pradaxa, Boehringer Ingelheim, Violations, Website, Code of Conduct, Prescripton Medicines Code of Practice Authority

Governments accused of impeding access in cutting medicine costs

Stockholm Network wrote 1 year ago: Andrew Witty, the chief executive of the United Kingdom’s largest pharmaceutical company GlaxoSmithK … more →

Tags: Health and Welfare, value based pricing, Patient Access, Andrew Witty, GlaxoSmithKline, Cost cutting, Medicines, drug prices


Related Tags
All →

Follow this tag via RSS